Land: Bretland
Tungumál: enska
Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)
Citalopram hydrobromide
Sun Pharma UK Ltd
N06AB04
Citalopram hydrobromide
40mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030300; GTIN: 5015525031137
2. What you need to know before you take Citalopram Tablets - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. Citalopram is also beneficial in relieving symptoms if you tend to suffer from panic attacks with or without agoraphobia (e.g. fear of leaving the house, entering shops, or fear of public places). 4. Possible side effects 1. WHAT CITALOPRAM TABLETS ARE AND WHAT ARE THEY USED FOR Also refer to the section “Other medicines and Citalopram” below. WARNINGS AND PRECAUTIONS - If you are taking medicines called monoamine oxidase inhibitors (MAOIs), or have stopped taking them within the past two weeks. Treatment must not begin any sooner than two weeks after you stop taking an irreversible MAO inhibitor, or the time specified by your doctor after you stop taking a reversible MAO inhibitor (e. g. moclobemide). Your doctor will tell you how to begin taking Citalopram Tablets once you have stopped taking the MAOI. At least one week should pass after you stop taking Citalopram Tablets before beginning treatment with a MAO inhibitor. 6. Contents of the pack and other information - If you are born with or have had an episode of abnormal heart rhythm (seen at ECG; an examination to evaluate how the heart is functioning). - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. What is Citalopram used for? WHAT IS IN THIS LEAFLET 3. How to take Citalopram Tablets 5. How to store Citalopram Tablets 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CITALOPRAM TABLETS How does Citalopram work? Citalopram contains citalopram and is used for the treatment of depression and, when you feel better, to help prevent these symptoms recurring. Citalopram is also used for long-term treatment to prevent the occurrence of new episodes of depression if you have recurrent depression. DO NOT TAKE CITALOPRAM TABLETS: Citalopram is a Selective Sero Lestu allt skjalið
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Citalopram 40 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 50 mg citalopram hydrobromide equivalent to 40 mg citalopram. Excipients with known effect: Lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated Tablet White to off-white circular biconvex film-coated tablet debossed with '40' on one side and a lip shaped break line on the other side. The score line is not intended for breaking the tablet. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of depressive illness in the initial phase and as maintenance against potential relapse/recurrence. Citalopram is also indicated in the treatment of panic disorder with or without agoraphobia_._ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults_ _Major depressive episodes _ _ _ Citalopram should be administered as a single oral dose of 20 mg daily. Dependent on individual patient response, the dose may be increased to a maximum of 40 mg daily. In general, improvement in patients starts after one week, but may only become evident from the second week of therapy. As with all antidepressant medicinal products, dosage should be reviewed and adjusted, if necessary, within 3 to 4 weeks of initiation of therapy and thereafter as judged clinically appropriate. Although there may be an increased potential for undesirable effects at higher doses, if after some weeks on the recommended dose insufficient response is seen, some patients may benefit from having their dose increased up to a maximum of 40 mg a day (see section 5.1). Dosage adjustments should be made carefully on an individual patient basis, to maintain the patient at the lowest effective dose. Patients with depression should be treated for a sufficient period of at least 6 months to ensure that they are free from symptoms. _Panic Disorder_ _ _ _Adults _ A single oral dose of 10 mg is recommended for the first week before increasin Lestu allt skjalið